JP6158188B2 - 抗生物質としての新規なペプチド誘導体 - Google Patents

抗生物質としての新規なペプチド誘導体 Download PDF

Info

Publication number
JP6158188B2
JP6158188B2 JP2014532400A JP2014532400A JP6158188B2 JP 6158188 B2 JP6158188 B2 JP 6158188B2 JP 2014532400 A JP2014532400 A JP 2014532400A JP 2014532400 A JP2014532400 A JP 2014532400A JP 6158188 B2 JP6158188 B2 JP 6158188B2
Authority
JP
Japan
Prior art keywords
xaa
compound
certain embodiments
formula
ojiromycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014532400A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014534173A5 (enExample
JP2014534173A (ja
Inventor
マキシム、グアルティエリ
フィリップ、ビラン−ギヨ
アラン、ジボダン
シルビー、パジュ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOSOPHARM
Institut National de la Recherche Agronomique INRA
Original Assignee
NOSOPHARM
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NOSOPHARM, Institut National de la Recherche Agronomique INRA filed Critical NOSOPHARM
Publication of JP2014534173A publication Critical patent/JP2014534173A/ja
Publication of JP2014534173A5 publication Critical patent/JP2014534173A5/ja
Application granted granted Critical
Publication of JP6158188B2 publication Critical patent/JP6158188B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2014532400A 2011-09-28 2012-09-28 抗生物質としての新規なペプチド誘導体 Expired - Fee Related JP6158188B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201161540085P 2011-09-28 2011-09-28
EP11183034.5 2011-09-28
US61/540,085 2011-09-28
EP11183034 2011-09-28
PCT/EP2012/069166 WO2013045600A1 (en) 2011-09-28 2012-09-28 Novel peptide derivatives as antibiotics

Publications (3)

Publication Number Publication Date
JP2014534173A JP2014534173A (ja) 2014-12-18
JP2014534173A5 JP2014534173A5 (enExample) 2015-11-19
JP6158188B2 true JP6158188B2 (ja) 2017-07-05

Family

ID=47994311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014532400A Expired - Fee Related JP6158188B2 (ja) 2011-09-28 2012-09-28 抗生物質としての新規なペプチド誘導体

Country Status (10)

Country Link
US (1) US9260481B2 (enExample)
EP (1) EP2760881B1 (enExample)
JP (1) JP6158188B2 (enExample)
CN (1) CN103827138B (enExample)
CA (1) CA2845735A1 (enExample)
ES (1) ES2657930T3 (enExample)
IL (1) IL231664A0 (enExample)
IN (1) IN2014DN03010A (enExample)
RU (1) RU2014114996A (enExample)
WO (1) WO2013045600A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2961297C (en) * 2014-09-26 2024-06-04 Nosopharm Peptide derivatives as antibiotics and uses thereof
US9800971B2 (en) 2015-03-17 2017-10-24 Knowles Electronics, Llc Acoustic apparatus with side port
US10647746B2 (en) 2016-04-08 2020-05-12 Versitech Limited Antibacterial cyclic lipopeptides
US11667674B2 (en) 2016-04-08 2023-06-06 Versitech Limited Antibacterial cyclic lipopeptides
WO2024200838A1 (en) * 2023-03-31 2024-10-03 Nosopharm New odilorhabdins analogues as antibiotics against multi-resistant bacteria

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717299D0 (en) * 1987-07-22 1987-08-26 Nat Res Dev Peptides
FR2819514B1 (fr) 2001-01-12 2003-02-28 Rhobio Pseudopeptides antimicrobiens
US20110033389A1 (en) * 2009-04-29 2011-02-10 Zhifeng Chen Modified antibodies for passive immunotherapy
FR2946058A1 (fr) 2009-05-27 2010-12-03 Nosopharm Procede pour augmenter la diversite des metabolites secondaires d'interet produits par des micro-organismes

Also Published As

Publication number Publication date
RU2014114996A (ru) 2015-11-10
CA2845735A1 (en) 2013-04-04
US9260481B2 (en) 2016-02-16
EP2760881A1 (en) 2014-08-06
IL231664A0 (en) 2014-05-28
EP2760881B1 (en) 2017-11-01
US20150175659A1 (en) 2015-06-25
JP2014534173A (ja) 2014-12-18
CN103827138B (zh) 2016-05-25
CN103827138A (zh) 2014-05-28
IN2014DN03010A (enExample) 2015-05-08
ES2657930T3 (es) 2018-03-07
WO2013045600A1 (en) 2013-04-04

Similar Documents

Publication Publication Date Title
JP6158188B2 (ja) 抗生物質としての新規なペプチド誘導体
US11548916B2 (en) Anti-infective compound
KR101401658B1 (ko) 진세노사이드 컴파운드 ｋ 또는 이의 유도체로 된 항균제
EP2500022B1 (en) Antibacterial agent for drug-resistant bacteria and use of same
EP3111948A1 (en) New bicyclic lipopeptide, preparation and use as antimicrobial agent
KR102158205B1 (ko) 항균 활성을 갖는 신규한 고리형 리포펩타이드계 화합물 및 이의 용도
US12427129B2 (en) Application of compound amino acids in preparation of medicament for improving sensitivity of bacteria to antibiotics
KR102167324B1 (ko) 백본-고리형 펩타이드와의 조합물
JP5391373B2 (ja) 新規抗菌化合物
KR102142870B1 (ko) 백본-고리형 펩타이드와의 조합물
KR101501346B1 (ko) 왕머루포도나무 뿌리 추출물 및 이의 분획물을 유효성분으로 포함하는 반코마이신 내성 장구균 감염증 예방 또는 치료용 조성물
WO2012085177A1 (en) Nemaucin, an antibiotic produced by entomopathogenic xenorhabdus cabanillasii
CN120865346A (zh) 小分子抗菌多肽、制备方法及其应用
KR101344083B1 (ko) 폴리사이클릭 펩타이드 화합물을 포함하는 항균용 조성물 및 이의 생산방법
US20240000872A1 (en) Novel bacteriophage that lyses acinetobacter genus bacteria having resistance to antibiotics
KR101790296B1 (ko) 네트롭신을 유효성분으로 포함하는 그람음성 세균에 대한 폴리믹신의 항균 활성을 증가시키는 조성물
JP7678470B2 (ja) 抗菌剤
TWI409077B (zh) 新穎抗菌化合物
DAS et al. Herbal Therapy Against Pulmonary Diseases In Pig And Man With Typhonium trilobatum Schott (L.) Schott. An Indian Medicinal Plant.
Ahmed et al. Research Article Efficacy of Ethanolic Extract of Syzygium aromaticum in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections
HK1207868B (en) Combinations with a backbone-cyclized peptide

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150928

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150928

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160714

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160805

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20161107

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170509

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170607

R150 Certificate of patent or registration of utility model

Ref document number: 6158188

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees